Loading data for APVO — first visit, this takes a few seconds.
Aptevo Therapeutics Inc. (APVO)
NasdaqCM: APVO
· Precio en tiempo real · USD
2.73
-0.17 (-5.86%)
Al cierre: Aug 19, 2026, 8:00 PM
2.76
+1.10%
Fuera de horario: 5:55 PM
Aptevo Therapeutics Inc. (APVO) Stock Price, Analysis & Data
-5.86% (1D)
No hay datos disponibles
| Precio de compra | n/a |
| Capitalización de mercado | 4.14M |
| Ingresos (TTM) | n/a |
| Beneficio neto (TTM) | -26.35M |
| Beta | 1.65 |
| EPS (TTM) | 456.62 |
| Ratio PER (TTM) | 0.01 |
| Adelante PE | -0.26 |
| P/B (TTM) | 0.16 |
| P/S (TTM) | n/a |
| Earnings Date | n/a |
| Precio de venta | n/a |
| Volumen | 92,301 |
| Volumen medio (20D) | 52,556 |
| Abierto | 2.99 |
| Anterior Cerrar | 2.90 |
| Rango del día | 2.61 - 3.01 |
| Rango de 52 semanas | 2.61 - 48.78 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de APVO
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical bloo...
Industria Biotechnology
Sector Healthcare
IPO Fecha Jul 20, 2016
Empleados 33
Bolsa de Valores NasdaqCM
Símbolo bursátil APVO
Sitio web https://aptevotherapeutics.com
Desempeño financiero
En 2025, los ingresos de Aptevo Therapeutics fueron 0, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron -25.97M, un aumento de 7.61%.
Estados financierosSorpresa de resultados
Aptevo Therapeutics ha publicado sus resultados trimestrales en Aug 14, 2026:
